Evidence map›Paper›PMID 40764390›Full record

ReviewNature cell biology2025

Vimentin intermediate filaments as structural and mechanical coordinators of mesenchymal cells.

Ming Guo, Ian Y Wong, Andrew S Moore, Ohad Medalia, Jennifer Lippincott-Schwartz, David A Weitz, Robert D Goldman

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature cell biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Sensing forces that shape tumours.Nature nanotechnology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Genome-wide single-cell perturbation screens with VIPerturb-seq.bioRxiv : the preprint server for biology · 2026
    Article
  17. Article
  18. Calumenin prevents fibroblast senescence and lung aging by promoting vimentin proteostasis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ming GuoDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. guom@mit.edu.ORCID http://orcid.org/0000-0002-0016-4158
Ian Y WongSchool of Engineering, Legoretta Cancer Center, Brown University, Providence, RI, USA.ORCID http://orcid.org/0000-0002-9439-2548
Andrew S MooreJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA, USA.ORCID http://orcid.org/0009-0008-7037-6640
Ohad MedaliaDepartment of Biochemistry, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0003-0994-2937
Jennifer Lippincott-SchwartzJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA, USA.ORCID http://orcid.org/0000-0002-8601-3501
David A WeitzJohn A. Paulson School of Engineering and Applied Sciences, Department of Physics, Harvard University, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-6678-5208
Robert D GoldmanDepartment of Cell and Developmental Biology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.ORCID http://orcid.org/0000-0003-0383-1435

Funding

The role of Sirtuins in neurodegenerative diseaseP20GM109035 · NIGMS · BROWN UNIVERSITY · PI WONG, IAN Y · 2016 to 2025
$22.6M
Mechanobiology of Vimentin Intermediate Filaments in 3D Collective Cell MigrationR01GM140108 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GUO, MING, WONG, IAN Y · 2021 to 2025
$2.3M
NIGMS NIH HHS P20 GM109035NIGMS NIH HHS R01 GM140108Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) SNSF 310030 207453U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) P20GM109035U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R01GM140108
6 · The paper itself

Abstract

Vimentin is a cytoskeletal intermediate filament protein that governs the form and function of mesenchymal cells, although the mechanistic details have been poorly understood. Here we highlight recent findings that reveal the diverse role of vimentin in dynamically organizing intracellular architecture and enhancing mechanical resilience. The exceptional deformability of vimentin can now be understood from its high-resolution three-dimensional structure resolved using cryo-electron microscopy. Vimentin also organizes the motion and positioning of numerous organelles, including mitochondria and the nucleus. Furthermore, it synergizes with the actin cytoskeleton to protect cells from extreme mechanical deformations. Finally, vimentin expression in epithelial-mesenchymal transitions has a functional role in tumour invasion analogous to embryonic development and wound healing. These recent developments emphasize the importance of understanding the multifaceted roles of vimentin intermediate filaments in human health and disease.

Indexed as

Intermediate FilamentsMesenchymal Stem CellsVimentinActin CytoskeletonAnimalsEpithelial-Mesenchymal TransitionHumansVimentin

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.